RecruitingPhase 3NCT04574089
Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository
Medical Ethics Committee of Peking University Shenzhen Hospital
Sponsor
Peking University Shenzhen Hospital
Enrollment
50 participants
Start Date
May 1, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 55 Years
Inclusion Criteria4
- Aerobic vaginitis diagnosed based on present :
- Vaginal dischareg ;
- pH \> 4.5;
- Donders score≥3;
Exclusion Criteria6
- Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
- Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
- Pregnancy, lactation and intentional pregnancy;
- Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
- Allergic constitution and patients allergic to drug ingredients in this study;
- Those with poor compliance.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGExperimental: Baofukang Suppository 7 days
Experimental: Baofukang Suppository 7 days
DRUGExperimental: Baofukang Suppository 14 days
Experimental: Baofukang Suppository 14 days
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04574089
Related Trials
Prospective Evaluation of Infectious Vulvovaginitis on Wound Complication Rates After Vulvar Excision for Premalignant Lesions
NCT060704541 location
A Study of the Efficacy and Safety of WXSH0102 in Treating VCC Patients
NCT067710632 locations
Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge
NCT055573182 locations